威尔药业：上半年净利润7276.69万元，同比下降7.77%

Group 1 - The core viewpoint of the article highlights that Weir Pharmaceutical (603351) reported a decline in both revenue and net profit for the first half of 2025 [1] - The company achieved operating revenue of 674 million yuan, representing a year-on-year decrease of 2.1% [1] - The net profit attributable to shareholders was 72.77 million yuan, down 7.77% compared to the previous year [1] - Basic earnings per share were reported at 0.54 yuan [1] Group 2 - During the reporting period, the sales volume of synthetic lubricating base oil increased by 3.18% year-on-year [1] - However, the sales revenue from synthetic lubricating base oil experienced a decline of 3.52% [1]